Login to Your Account

After IPO, Portola Seeks Seconds with $105.9M Public Offering

By Marie Powers
Staff Writer

Thursday, October 17, 2013
Five months after closing its initial public offering (IPO), Portola Pharmaceuticals Inc. took advantage of the rise in its shares (NASDAQ:PTLA) to price an underwritten public offering of approximately 6.4 million shares of its common stock at $23.75 apiece.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription